MAPT and amyloidosis: Groups are as follows: Control = Control group of healthy individuals, No AD = iNPH patients with no AD pathology in brain biopsy, Aβ = iNPH patients with Aβ-pathology in brain biopsy, and Aβ + Tau = iNPH patients with both amyloid and tau pathology in brain biopsy.